(Q54650664)
Statements
Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome (English)
Emeline Tabouret
Aude Charbonnier
Marie-Joelle Mozziconacci
Vadim Ivanov
15 September 2010
35
1
136